decisionhealth Newsletters, Part B News - 2023 Issue 3 (March)
Fearing ‘telehealth cliff,’ orgs oppose DEA’s proposed time limits, in-person demands
Subscribe or sign in to view the full article.
Article Overview
This article explains how health care organizations are responding to DEA proposals that would change telehealth prescribing rules after the COVID-19 public health emergency. It covers the proposed in-person evaluation requirements, time limits, effects on patient access and specialty care, and the opportunity for public comment. The piece is relevant to clinicians, addiction medicine, psychiatry, telehealth stakeholders, and compliance professionals tracking federal controlled-substance policy.
Why This Topic Matters
The proposed DEA rules could affect telehealth operations, continuity of care, and access to treatment for patients who rely on remote services. Readers involved in prescribing, addiction treatment, psychiatry, compliance, or telehealth policy need to understand the scope of the proposed changes and the comment deadline.
Article Sections
-
In-person requirements: Too much, too late?
This section summarizes health care organizations’ concerns about proposed telehealth restrictions and how they may affect access to care, especially for patients with ongoing treatment needs.
-
You still have time to comment
This section covers the public comment period, stakeholder reactions, and general themes organizations suggest commenters may raise in response to the proposed rules.
What You Will Learn
- What the DEA proposed for telehealth-related prescribing after the public health emergency
- Why health care organizations are concerned about access and continuity of care
- How the proposed changes could affect addiction treatment and psychiatric care
- What the article says about the public comment process and stakeholder advocacy
Who Should Read This
- Physicians and prescribers
- Addiction medicine clinicians
- Psychiatrists and behavioral health providers
- Telehealth administrators
- Compliance and regulatory professionals
- Health care policy readers
Subscribe or sign in to view the full article.


Quick, Current, Complete - www.findacode.com